• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 IV; FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 IV; FREE THYROXINE Back to Search Results
Catalog Number ASKU
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/24/2023
Event Type  malfunction  
Event Description
The initial reporter stated they received questionable values for six patient samples tested with thyroid assays on two cobas e 801 module analyzers and a cobas e 411 analyzer.Results for the following assays were affected: elecsys tsh, elecsys ft4 iv, and elecsys ft3 iii.The specific date of the event is not known.This medwatch will cover the ft4 assay.Please refer to the medwatch with a1.Patient identifier (b)(6) for information related to the tsh assay and refer to the medwatch with a1.Patient identifier (b)(6) for information related to the ft3 assay.Refer to the attachment for all patient data.The values highlighted in yellow were questioned.Samples were initially tested on the customer's e 801 analyzer on an unknown date.The samples were provided for investigation, where they were tested on a second e 801 analyzer and an e411 analyzer on (b)(6) 2023.The samples were repeated on an abbott architect analyzer on (b)(6) 2023.
 
Manufacturer Narrative
The serial number of the customer's e 801 analyzer is unknown.The ft4 reagent lot number and expiration date used on this analyzer were requested, but not provided.The serial number of the e 801 analyzer used for investigation is (b)(6).Ft4 reagent lot (b)(4), with an expiration date of 01-nov-2023 was used on this analyzer.The serial number of the e411 analyzer used for investigation is (b)(4).Ft4 reagent lot (b)(6), with an expiration date of 01-oct-2023 was used on this analyzer.The investigation is ongoing.
 
Manufacturer Narrative
Of the 6 patient samples, further investigations were performed with sample id (b)(6).Investigations of this sample determined that it contains an interfering factor against the streptavidin components of the ft3 and ft4 assays.Per product labeling, "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design." for all other samples and for tsh values of sample id (b)(6), the difference in results relates to differences in the setups of the assays, the antibodies used, and differences in the standardization materials and procedures used.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 IV
Type of Device
FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17785467
MDR Text Key324121188
Report Number1823260-2023-03031
Device Sequence Number1
Product Code CEC
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
K220456
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU, 670634, 663936
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/29/2023
Initial Date FDA Received09/20/2023
Supplement Dates Manufacturer Received12/28/2023
Supplement Dates FDA Received01/02/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-